Bio-Techne Corporation (TE1.F)
| Previous close | 71.00 |
| Open | 73.50 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 73.50 - 74.50 |
| 52-week range | 49.40 - 80.50 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 11.828B |
| Beta (5Y monthly) | 1.23 |
| PE ratio (TTM) | 64.22 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.30 (0.40%) |
| Ex-dividend date | 10 May 2024 |
| 1y target est | N/A |
- PR Newswire
BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024
Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the BofA Securities Health Care Conference on Tuesday, May 14, 2024, at 2:20 p.m. PDT. A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.
- PR Newswire
BIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT)
Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its portfolio of cell and gene therapy workflow solutions at the upcoming annual meeting of the American Society of Gene & Cell Therapy (ASGCT), taking place May 7-11, 2024, in Baltimore, Maryland.
- PR Newswire
BIO-TECHNE DECLARES DIVIDEND
Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended March 31, 2024. The quarterly dividend will be payable May 24, 2024, to all common shareholders of record on May 13, 2024. Future cash dividends will be considered by the Board of Directors on a quarterly basis.
